Vor Income Before Tax from 2010 to 2025
| VOR Stock | USD 0.87 0.02 2.35% |
Income Before Tax | First Reported 2019-12-31 | Previous Quarter -27.6 M | Current Value -30.7 M | Quarterly Volatility 8.5 M |
Check Vor Biopharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vor Biopharma's main balance sheet or income statement drivers, such as Net Interest Income of 4.5 M, Interest Income of 4.5 M or Depreciation And Amortization of 3.4 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.75. Vor financial statements analysis is a perfect complement when working with Vor Biopharma Valuation or Volatility modules.
Vor | Income Before Tax |
Latest Vor Biopharma's Income Before Tax Growth Pattern
Below is the plot of the Income Before Tax of Vor Biopharma over the last few years. Income Before Tax which can also be referred as pre-tax income is reported on Vor Biopharma income statement and is an important metric when analyzing Vor Biopharma profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability. It is Vor Biopharma's Income Before Tax historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vor Biopharma's overall financial position and show how it may be relating to other accounts over time.
| Income Before Tax | 10 Years Trend |
|
Income Before Tax |
| Timeline |
Vor Income Before Tax Regression Statistics
| Arithmetic Mean | (37,398,894) | |
| Geometric Mean | 13,770,990 | |
| Coefficient Of Variation | (125.22) | |
| Mean Deviation | 40,722,742 | |
| Median | (4,152,000) | |
| Standard Deviation | 46,830,908 | |
| Sample Variance | 2193.1T | |
| Range | 113.7M | |
| R-Value | (0.86) | |
| Mean Square Error | 594.4T | |
| R-Squared | 0.75 | |
| Significance | 0.000016 | |
| Slope | (8,501,712) | |
| Total Sum of Squares | 32897T |
Vor Income Before Tax History
About Vor Biopharma Financial Statements
Vor Biopharma shareholders use historical fundamental indicators, such as Income Before Tax, to determine how well the company is positioned to perform in the future. Although Vor Biopharma investors may analyze each financial statement separately, they are all interrelated. The changes in Vor Biopharma's assets and liabilities, for example, are also reflected in the revenues and expenses on on Vor Biopharma's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Income Before Tax | -116.9 M | -111.1 M |
Additional Tools for Vor Stock Analysis
When running Vor Biopharma's price analysis, check to measure Vor Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vor Biopharma is operating at the current time. Most of Vor Biopharma's value examination focuses on studying past and present price action to predict the probability of Vor Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vor Biopharma's price. Additionally, you may evaluate how the addition of Vor Biopharma to your portfolios can decrease your overall portfolio volatility.